FDA Approves Drug for Neuropathy Pain


| Dec 1, 2005

Pfizer, Inc., announced on September 21, 2005, that Lyrica (pregabalin) capsules are now available for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN), postherpetic neuralgia (PHN) and adjunctive treatment of partial onset seizures in adults with epilepsy.

“Until now, we’ve had limited options to treat patients with these types of neuropathic pain,” says Edgar Ross, MD, director of the Pain Management Center at Brigham and Women’s Hospital in Boston. “I have seen the benefits of Lyrica in providing rapid and sustained pain relief among my patients in the clinical trials.”

According to Pfizer, Lyrica is the first treatment approved by the U.S. Food and Drug Administration to treat two distinct forms of neuropathic pain and is the first new antiepileptic drug introduced in five years.

Lyrica is available in pharmacies nationwide. For more information, log on to www.lyrica.com.

Source: Pfizer, Inc.

What Is Neuropathic Pain?

Neuropathic pain is caused by nerve damage that can result from underlying conditions, such as diabetes or shingles. Nearly half of the 18 million Americans with diabetes will develop some form of diabetic neuropathy over the course of their disease and will suffer from neuropathic pain.

Source: Pfizer, Inc.

Side Effects of Lyrica

The most common side effects of Lyrica are dizziness, sleepiness, dry mouth, swelling of hands and feet, blurred vision, weight gain and trouble concentrating. Patients with a history of drug or alcohol abuse may have a higher chance of misuse or abuse of Lyrica.

Source: Pfizer, Inc.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Food, Nerve Care (Neuropathy), Type 1 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.